Difference between revisions of "Atezolizumab (Tecentriq)"
Jump to navigation
Jump to search
m |
m |
||
| Line 8: | Line 8: | ||
[[Category:Immunotherapy]] | [[Category:Immunotherapy]] | ||
| + | [[Category:T-cell activators]] | ||
[[Category:Antibody medications]] | [[Category:Antibody medications]] | ||
[[Category:Anti-PD-L1 antibodies]] | [[Category:Anti-PD-L1 antibodies]] | ||
[[Category:Investigational]] | [[Category:Investigational]] | ||
Revision as of 23:10, 17 December 2014
Mechanism of action
A human, Fc optimized, monoclonal antibody directed against the protein ligand PD-L1 (programmed cell death-1 ligand 1)
Also known as
RG7446